The presence of tumor necrosis is an adverse prognostic factor in follicular dendritic cell sarcoma.
About the Disease
References:1. Jaffe, E. S. et al (2017). Hematopathology - Second Edition. Philadelphia, PA. Elsevier. 2. Lorenzi, L. et al. Identification of novel follicular dendritic cell sarcoma markers, FDCSP and SRGN, by whole transcriptome sequencing. Oncotarget, 2017, Vol. 8, (No.10), pp:16463-16472.